MECOM and acute myeloid leukemia: Accordingly, the BET-bromodomain inhibitor JQ1 decreased EVI1 mRNA levels, inhibited proliferation, and augmented the differentiation and apoptosis of AML cells overexpressing EVI1 due to specific chromosome rearrangements [37].